We recently published a list of These 10 Stocks Blew Past Expectations. In this article, we are going to take a look at where ...

The company's stock jumped 15% as of market close. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite ...

Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor ...

Like any soulslike fan, I’m quite accustomed to the process of dying over and over again until I’ve mastered a tough section, but playing through AI Limit was the first time I felt that sense ...

Spruce Point Capital Management has announced a new short position against Tempus AI Inc (NASDAQ:TEM). The short seller on ...

Tempus AI stock is trading at a nosebleed valuation, and despite the compelling long-term upside, it's not worth investing at ...

Amid volatile trade and rising uncertainty, these momentum stocks have shown strong signs of leadership in the first half of ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration to develop ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In its first-quarter 2025 investor letter, Baron Discovery Fund highlighted stocks such as Tempus AI, Inc. (NASDAQ:TEM) . Tempus AI, Inc. (NASDAQ:TEM) is a healthcare technology company.

Tempus AI (NASDAQ:TEM) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their recent ...

Pathos says that its AI model will enable researchers to discover new biomarkers more efficiently. In April, the company partnered with AstraZeneca plc and healthcare technology company Tempus ...